Patents by Inventor Sieger Adriaan Nelemans

Sieger Adriaan Nelemans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20190135867
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Application
    Filed: January 14, 2019
    Publication date: May 9, 2019
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rink, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • Angiotensin type 2 (AT2) receptor agonists and uses thereof
    Patent number: 10214563
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: February 26, 2019
    Assignee: LANTHIOPEP B.V.
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rink, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • NOVEL ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS AND USES THEREOF
    Publication number: 20170283465
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Application
    Filed: June 8, 2017
    Publication date: October 5, 2017
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rink, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • Angiotensin type 2 (AT2) receptor agonists and uses thereof
    Patent number: 9707268
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: July 18, 2017
    Assignee: LANTHIOPEP B.V.
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rinck, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • Novel Angiotensin Type 2 (AT2) Receptor Agonists and Uses Thereof
    Publication number: 20160220632
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Application
    Filed: January 29, 2016
    Publication date: August 4, 2016
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rinck, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • Angiotensin Type 2 (AT2) receptor agonists and uses thereof
    Patent number: 9290540
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: March 22, 2016
    Assignee: Lanthio Pep B.V.
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rink, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • Cyclic angiotensin analogs
    Patent number: 8835375
    Abstract: The invention relates to analogs of angiotensins, in particular to cyclised analogs having Ang(1-8) agonistic or antagonistic activity and to cyclised Ang(1-7) analogs with agonistic or antagonistic activity and displaying improved proteolytic resistance compared to their linear counterparts. Provided is a cyclic angiotensin peptide analog comprising a thioether-bridge linkage between the amino acids corresponding to positions Tyr4 and Pro7 in naturally occurring Angiotensin. Also provided is the use of analogs in therapy, for example hypertension.
    Type: Grant
    Filed: August 7, 2007
    Date of Patent: September 16, 2014
    Assignee: Applied Nanosystems B.V.
    Inventors: Marijke Haas, Leonardus Dorothea Kluskens, Anneke Kuipers, Rick Rink, Sieger Adriaan Nelemans, Gert Nikolaas Moll
  • Novel Angiotensin Type 2 (AT2) Receptor Agonists and Uses Thereof
    Publication number: 20140094400
    Abstract: The invention relates to novel pharmaceutically-useful peptides, in particular cyclic peptides that are agonists of the AngII type 2 receptor (AT2 receptor). The invention further relates to the use of such peptides as medicaments, to pharmaceutical compositions containing them, and to their production.
    Type: Application
    Filed: November 22, 2011
    Publication date: April 3, 2014
    Applicant: LANTHIOPEP B.V.
    Inventors: Louwe De Vries, Sieger Adriaan Nelemans, Rick Rink, Antonius Jacobus Marinus Roks, Gert Nikolaas Moll
  • CYCLIC ANGIOTENSIN ANALOGS
    Publication number: 20100055146
    Abstract: The invention relates to analogs of angiotensins, in particular to cyclised analogs having Ang(1-8) agonistic or antagonistic activity and to cyclised Ang(1-7) analogs with agonistic or antagonistic activity and displaying improved proteolytic resistance compared to their linear counterparts. Provided is a cyclic angiotensin peptide analog comprising a thioether-bridge linkage between the amino acids corresponding to positions Tyr4 and Pro7 in naturally occurring Angiotensin. Also provided is the use of analogs in therapy, for example hypertension.
    Type: Application
    Filed: August 7, 2007
    Publication date: March 4, 2010
    Inventors: Marijke Haas, Leonardus Dorothea Kluskens, Anneke Kuipers, Rick Rink, Sieger Adriaan Nelemans, Gert Nikolaas Moll